Plants mobilize their immune defenses far earlier than scientists have believed for decades—and through a previously ...
Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...
How to make safe, efficient, and robust products By Paulius Juskevicius, Littelfuse, Inc. Consumers enjoy the benefits of ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Equipment failure leads to mechanical problems at Sacred Heart Parish in West Reading, power outages
About 3,600 Met-Ed customers in Reading and West Reading lost power Monday morning due to a Met-Ed equipment failure. The problem was discovered shortly before 9 a.m. Power restored by noon. Around ...
With a modular design that supports up to 100kW of DC fast charging output, this new collaborative charging platform gives businesses, municipalities, and fleet operators a scalable solution to ...
Quarterback Jared Goff turned in his worst performance of the season during the 16-9 loss in Week 11 against the Philadelphia Eagles. Goff struggled in part because the Detroit Lions offensive line ...
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without ...
On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in ...
Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.
Based on these trial results, Lilly will begin enrolling Phase 3 clinical studies for the treatment of obesity next month "Obesity is a complex condition, and no single treatment works for everyone.
Sen. Kelda Roys, D-Madison, announced the Pregnancy Loss Protection Act Dec. 2, which would protect those who experience pregnancy loss from prosecution, according to a press release. This bill would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results